Seralutinib for the Treatment of Pulmonary Arterial Hypertension (PAH): Results From the Phase 2 TORREY Trial

Autor:	R.P. Frantz, V.V. McLaughlin, S. Sahay, P. Escribano Subías, R.L. Zolty, R.L. Benza, R.N. Channick, K.M. Chin, A.R. Hemnes, L.S. Howard, O. Sitbon, J.-L. Vachiery, R.T. Zamanian, M. Cravets, R.F. Roscigno, D. Mottola, E. Elman, E. Parsley, R. Aranda, L.S. Zisman, H.-A. Ghofrani, null on behalf of the TORREY Study Investigators
Rok vydání:	2023
Zdroj:	D106. HOT OFF THE PRESSES! LATE BREAKERS IN PULMONARY VASCULAR DISEASE.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4dc0a17d77c079aa92f92c5e5413a1f1 https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6726 Zobrazit plný text záznamu